TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables

Laboratory
optical and precision equipments (excl. glasses)
North West (UKD62)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.3Bids / Report
66.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published16 Nov 2021, 15:45 GMT
Last source update16 Nov 2021, 15:45 GMT
Recurring procurementNot published
ClassificationLaboratory, optical and precision equipments (excl. glasses)
Delivery area
North West (UKD62)
OCIDocds-h6vhtk-02f737
What is being bought
The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables.
What changed
From the official release history
  1. Status changed to complete
    16 Nov 2021, 15:45 GMT
  2. Official notice release published
    16 Nov 2021, 15:45 GMT
  3. Buyer information updated
    16 Nov 2021, 15:45 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables to the Medicines Discovery Catapult Ltd. The Illumina NextSeq 1000 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and secondary analysis. The system includes embedded touchscreen monitor and on-instrument computer, control software, hardware accelerated analysis pipelines. The contract includes delivery, installation, maintenance and training. The associated consumables are also included in the scope of this contract.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    16 Nov 2021, 15:45 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 16 Nov 2021, 00:00 GMT · £300,000
Commercial outcome and competition
Awards
Illumina Cambridge Ltd
Not published · Not published · active
Contracts
Contract
£300,000 · signed 16 Nov 2021, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-23690
View buyer profile

  • Medicines Discovery Catapult
    buyer

    Block 35, Mereside, Alderley Park, Cheshire, UKD62, SK10 4ZF
    laura.hough@md.catapult.org.uk
    +44 1625708394

  • Illumina Cambridge Ltd
    supplier

    Essex, UKD62

  • Medicines Discovery Catapult
    reviewBody

    Alderley Edge
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Illumina sequencer for GeoMx is required by the Medicines Discovery Catapult Ltd (MDC) as it forms part of the GeoMx workflow for whole spatial transcriptome analysis. Illumina sequencer for GeoMx is required, there is no competition and competition is absent for technical reasons as the Illumina sequencer for GeoMx is the only instrument which has access to Illumina adapters within the nanostring reagents. Nanostring have developed a workflow with Illumina where Illumina’s i5 and i7 sequences specifically add P5 and P7 sequences for binding to Illumina’s flow cell. These sequences are part of the SeqCode that are for the library prep and there are no alternative sequences to obtain for analysis. Furthermore, the software offers a selection of Illumina sequencers to choose from when finalizing the readout group (to be able to start sequencing) – this will create files that are tailored towards use on the respective Illumina platforms. Most of all, the sequences (FASTQ files) need to be processed in order to be made compatible with the GeoMx for import. The pipeline software is tailored to work with the Illumina output files (including Illumina’s index sequences) and cannot be used on sequences produced by any other system. Or you can directly process these files within Illumina’s BaseSpace environment. The purchase of the equipment will enable a fully integrated workflow of the two systems. The MDC will follow a 10 day standstill period ending on midnight on Friday 26th November 2021. Following the successful completion of the standstill period the MDC will award the contract to Illumina Cambridge Ltd.